Matches in SemOpenAlex for { <https://semopenalex.org/work/W2467607334> ?p ?o ?g. }
- W2467607334 endingPage "e0157721" @default.
- W2467607334 startingPage "e0157721" @default.
- W2467607334 abstract "Introduction Immunosuppressive agents (ISA) have been used in multiple sclerosis (MS) for decades, frequently as off label licensed therapies. Given the new MS treatment landscape, what place do ISA have in combating MS? Methods We conducted a retrospective multicentre study to investigate the frequency of ISA prescription in 17 Italian MS centres, and to describe the clinical factors related to ISA use. Results Out of 6,447 MS patients, 2,034 (31.6%) were treated with ISA, with Azathioprine being the most frequently used ISA overall. MS patients treated with ISA alone were more frequently affected by the progressive course (both primary and secondary) of the disease (RRR 5.82, 95% CI 4.14–8.16, p<0.0001), had higher EDSS (RRR 3.69, 95% CI 2.61–5.21, p<0.0001), higher assignment age (RRR 1.04, 95% CI 1.03–1.06, p<0.0001) than patients treated with only disease modifying drugs (DMDs). Conclusions Progressive course, higher EDSS, higher assignment age were the strongest predictors of ISA prescription and use in our population." @default.
- W2467607334 created "2016-07-22" @default.
- W2467607334 creator A5000230349 @default.
- W2467607334 creator A5008399548 @default.
- W2467607334 creator A5012645417 @default.
- W2467607334 creator A5018024307 @default.
- W2467607334 creator A5019405727 @default.
- W2467607334 creator A5022017469 @default.
- W2467607334 creator A5023725739 @default.
- W2467607334 creator A5032038912 @default.
- W2467607334 creator A5034216940 @default.
- W2467607334 creator A5034370732 @default.
- W2467607334 creator A5036399196 @default.
- W2467607334 creator A5046530867 @default.
- W2467607334 creator A5049145342 @default.
- W2467607334 creator A5051776174 @default.
- W2467607334 creator A5062156098 @default.
- W2467607334 creator A5063501464 @default.
- W2467607334 creator A5071409158 @default.
- W2467607334 creator A5076662458 @default.
- W2467607334 creator A5079358503 @default.
- W2467607334 creator A5083385630 @default.
- W2467607334 creator A5086425939 @default.
- W2467607334 date "2016-06-27" @default.
- W2467607334 modified "2023-10-04" @default.
- W2467607334 title "The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study" @default.
- W2467607334 cites W162969009 @default.
- W2467607334 cites W1943010815 @default.
- W2467607334 cites W1974941970 @default.
- W2467607334 cites W1978510680 @default.
- W2467607334 cites W1983921455 @default.
- W2467607334 cites W1986991730 @default.
- W2467607334 cites W2008803633 @default.
- W2467607334 cites W2013481339 @default.
- W2467607334 cites W2023475282 @default.
- W2467607334 cites W2024185549 @default.
- W2467607334 cites W2026091205 @default.
- W2467607334 cites W2037980570 @default.
- W2467607334 cites W2042166711 @default.
- W2467607334 cites W2061256506 @default.
- W2467607334 cites W2087589796 @default.
- W2467607334 cites W2094701397 @default.
- W2467607334 cites W2095116045 @default.
- W2467607334 cites W2105206040 @default.
- W2467607334 cites W2112165124 @default.
- W2467607334 cites W2130355701 @default.
- W2467607334 cites W2136139535 @default.
- W2467607334 cites W2136266325 @default.
- W2467607334 cites W2142311493 @default.
- W2467607334 cites W2142577589 @default.
- W2467607334 cites W2171100984 @default.
- W2467607334 cites W2179093540 @default.
- W2467607334 cites W2235497281 @default.
- W2467607334 cites W2916040650 @default.
- W2467607334 doi "https://doi.org/10.1371/journal.pone.0157721" @default.
- W2467607334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4922668" @default.
- W2467607334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27348606" @default.
- W2467607334 hasPublicationYear "2016" @default.
- W2467607334 type Work @default.
- W2467607334 sameAs 2467607334 @default.
- W2467607334 citedByCount "5" @default.
- W2467607334 countsByYear W24676073342019 @default.
- W2467607334 countsByYear W24676073342021 @default.
- W2467607334 countsByYear W24676073342022 @default.
- W2467607334 countsByYear W24676073342023 @default.
- W2467607334 crossrefType "journal-article" @default.
- W2467607334 hasAuthorship W2467607334A5000230349 @default.
- W2467607334 hasAuthorship W2467607334A5008399548 @default.
- W2467607334 hasAuthorship W2467607334A5012645417 @default.
- W2467607334 hasAuthorship W2467607334A5018024307 @default.
- W2467607334 hasAuthorship W2467607334A5019405727 @default.
- W2467607334 hasAuthorship W2467607334A5022017469 @default.
- W2467607334 hasAuthorship W2467607334A5023725739 @default.
- W2467607334 hasAuthorship W2467607334A5032038912 @default.
- W2467607334 hasAuthorship W2467607334A5034216940 @default.
- W2467607334 hasAuthorship W2467607334A5034370732 @default.
- W2467607334 hasAuthorship W2467607334A5036399196 @default.
- W2467607334 hasAuthorship W2467607334A5046530867 @default.
- W2467607334 hasAuthorship W2467607334A5049145342 @default.
- W2467607334 hasAuthorship W2467607334A5051776174 @default.
- W2467607334 hasAuthorship W2467607334A5062156098 @default.
- W2467607334 hasAuthorship W2467607334A5063501464 @default.
- W2467607334 hasAuthorship W2467607334A5071409158 @default.
- W2467607334 hasAuthorship W2467607334A5076662458 @default.
- W2467607334 hasAuthorship W2467607334A5079358503 @default.
- W2467607334 hasAuthorship W2467607334A5083385630 @default.
- W2467607334 hasAuthorship W2467607334A5086425939 @default.
- W2467607334 hasBestOaLocation W24676073341 @default.
- W2467607334 hasConcept C126322002 @default.
- W2467607334 hasConcept C167135981 @default.
- W2467607334 hasConcept C187212893 @default.
- W2467607334 hasConcept C203014093 @default.
- W2467607334 hasConcept C2426938 @default.
- W2467607334 hasConcept C2776760755 @default.
- W2467607334 hasConcept C2779134260 @default.
- W2467607334 hasConcept C2780640218 @default.
- W2467607334 hasConcept C2908647359 @default.
- W2467607334 hasConcept C71924100 @default.